<DOC>
	<DOCNO>NCT00569244</DOCNO>
	<brief_summary>The investigational drug SH T00186D oral contraceptive . The investigational drug use study contain estrogen ethinylestradiol ( EE ) progestogen drospirenone ( DRSP ) . The aim present study evaluate efficacy safety investigational drug treatment menstrual pain ( pelvic pain occur shortly , onset , menstruation ) . Two different regimen intake investigational product compare . Patients undergo 2 -3 Baseline cycle ( depend whether patient OC user ) , menstrual pain , bleed event , pain killer intake document . During observation period , intake hormonal contraceptive allow . Other contraceptive method ( condom spermicide , pessary spermicide ) use . If patient eligible study , randomly assign one two treatment group . Treatment group A take medication accord extend flexible regimen , i.e. , tablet intake trigger bleeding event . Treatment group B take study medication 24 + 4 day regimen . That mean , tablet take cycle day 1 - 24 contain hormone combination , whereas tablet 25 - 28 contain active ingredient , i.e. , call placebo tablet . Treatment last least 140 day , prolonged Treatment Group A depend occurrence menstrual bleeding . The overall study duration 10 month patient . During whole study period , 5 visit plan . At Screening Final examination , thorough physical examination gynecological examination ( include breath palpation cervical smear ) perform . Blood sample take safety laboratory parameter . Additional examination perform time , becomes necessary medical reason . Patients provide patient diary document intake study medication , bleed event day without bleeding , pregnancy test result , dysmenorrheic ( menstrual ) pain intensity interference daily activity , intake pain medication . The pain medication ( ibuprofen ) provide .</brief_summary>
	<brief_title>SH T00186 Treatment Primary Dysmenorrhea</brief_title>
	<detailed_description />
	<mesh_term>Dysmenorrhea</mesh_term>
	<criteria>Otherwise healthy female patient moderate severe primary dysmenorrhea Prospective selfrated sum pain score &gt; /= 8 2 baseline cycle Age 18 40 year ( inclusive ) smoke habit follow : 18 30 year age . daily cigarette consumption 10 30 year age , smoke Current sign history form secondary dysmenorrhea Any concomitant disease condition require intake analgesic medication Occurrence le six menstrual cycle Visit 1 follow delivery , abortion , lactation Clinically significant depression</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Primary Dysmenorrhea</keyword>
	<keyword>Menstrual Pain</keyword>
	<keyword>Oral Contraception</keyword>
</DOC>